Source: International Congress 2019 – Airway diseases and blood cells
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Carrasco Hernandez (Sevilla, Spain), F. Puig Rodriguez (Sevilla, Spain), M. Espinoza Solano (Sevilla, Spain), E. Márquez Martín (Sevilla, Spain), F. Órtega Ruiz (Sevilla, Spain), J. López-Campos (Sevilla, Spain). Use of inhaled corticoids and presence of eosinophilia in patients with COPD: TRACE Cohort. 2571

Member's Comments

No comment yet.

Related content which might interest you: The impact of stepwise withdrawal of inhaled corticosteroids on exacerbations in COPD patients receiving dual bronchodilation: WISDOM study Source: International Congress 2014 – Bronchodilators for asthma and COPD Year: 2014 The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Use of Inhaled corticosteroid (ICS)-containing regimen for COPD patients with high or low blood eosinophilia: A meta-analysis Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018 Clinical experience with montelukast plus ICS vs. only ICS in non-asthmatic eosinophilic bronchitis (NAEB) in Indian patients Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 A prospective study of the effect of carbocysteine lysine salt on COPD exacerbations with or without inhaled steroids Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases Year: 2014 Treatment failure of hospitalized patients with COPD exacerbation using systemic corticosteroids plus antibiotics: Role of early inflammatory predictors Source: International Congress 2014 – Asthma and COPD management Year: 2014 Microbiome Use to Stratify Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (MUSIC) trial: baseline data and impact of inhaled corticosteroid withdrawal in severe COPD with frequent exacerbations Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils Year: 2020 Study of some inflammatory markers in children with moderate persistent bronchial asthma before and after therapy with inhaled corticosteroids Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Effect of QVA149 on lung function in the subgroup of patients with a history of exacerbations in the previous year and baseline ICS use from the SHINE study Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Blood eosinophil guided prednisolone therapy for exacerbations of COPD: A further analysis Source: International Congress 2014 – COPD exacerbations Year: 2014 A new user cohort study comparing the risk of pneumonia in inhaled corticosteroid (ICS) vs. long-acting bronchodilator (LABD) regimens in COPD Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 The effect of twice-daily aclidinium bromide on cough and sputum in patients with COPD: Results from phase III studies Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Association between inhaled corticosteroid use in COPD and incidence or worsening of type2 diabetes Source: International Congress 2014 – Markers Year: 2014 Hemodynamic effects of inhaled fenoterol and ipratropium in patients with obstructive pulmonary diseases Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results Source: Eur Respir J 2009; 34: 641 Year: 2009 Phase III trial of tiotropium as add-on therapy to low-dose inhaled corticosteroids for patients with symptomatic mild persistent asthma: Design and planned analyses Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 Study on sputum differential counts in asthmatics controlled & uncontrolled on inhaled corticosteroids Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Effect of aclidinium bromide on exacerbations in patients with moderate-to-severe COPD: Pooled analysis of phase III studies Source: International Congress 2014 – Bronchodilators for asthma and COPD Year: 2014 Eligibility of patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: Lung function and safety Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD Year: 2013